Correlation between oxidative stress and cognitive impairment in patients with obstructive sleep apnea-hypopnea syndrome
Abstract
Background/Aim. It is necessary to find relevant oxidative stress markers for predicting the severity of obstructive sleep apnea-hypopnea syndrome (OSAHS), a sleep disorder-related respiratory disease. The aim of the study was to investigate if there is a correlation between oxidative stress and cognitive impairment in OSAHS patients. Methods. A total of 220 patients were divided into the group of snoring patients, the group with mild to moderate OSAHS, and the group with severe OSAHS according to polysomnography (PSG). Apnea-hypopnea index (AHI), oxygen desaturation index (ODI), and baseline data were monitored. Oxidative stress indices were measured by colorimetry from blood samples taken early in the morning. The patients were then divided into the group with normal cognition and cognitive impairment group based on mini-mental state examination (MMSE) and Montreal cognitive assessment (MoCA). Independent risk factors for cognitive impairment were analyzed by multivariate logistic regression. The correlation between oxidative stress and cognitive impairment was analyzed by Pearson’s method. Receiver operating characteristic (ROC) curves made it possible to analyze the efficiency of oxidative stress combined with detection for assessing cognitive impairment in OSAHS patients. Results. The snoring group, mild to moderate OSAHS group, and severe OSAHS group had significantly different snoring loudness, body mass index (BMI), AHI, ODI, MoCA, and MMSE scores, and levels of malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) (p < 0.05). The cognitive impairment group and group with normal cognition had different BMI, GSH-Px, MDA, SOD, neuroglobin, hypoxia-inducible factor, AHI, and lowest nocturnal oxygen saturation (p < 0.05 or p < 0.01) levels. BMI, GSH-Px, MDA, SOD, neuroglobin, hypoxia-inducible factor, AHI, and lowest nocturnal oxygen saturation were independent risk factors for cognitive impairment. The MoCA and MMSE scores of cognitive impairment had positive correlations with GSH-Px and SOD but negative correlations with MDA (p < 0.05). The area under the ROC curve of GSH-Px, MDA, and SOD and their combination for prediction of cognitive impairement were 0.670, 0.702, 0.705, and 0.836, respectively. Conclusion. Oxidative stress may be the biochemical basis of cognitive impairment in OSAHS patients.
References
1. He Y, Chen R, Wang J, Pan W, Sun Y, Han F, et al. Neurocognitive impairment is correlated with oxidative stress in patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome. Respir Med 2016; 120: 25‒30.
2. Mancuso M, Bonanni E, LoGerfo A, Orsucci D, Maestri M, Chico L, et al. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med 2012; 13(6): 632‒6.
3. Dumortier L, Bricout VA. Obstructive sleep apnea syndrome in adults with down syndrome: Causes and consequences. Is it a" chicken and egg" question? Neurosci Biobehav Rev 2020; 108: 124‒38.
4. Wang Y, Li B, Li P, Gong T, Wu M, Fu J, et al. Severe obstructive sleep apnea in patients with chronic obstructive pulmonary disease is associated with an increased prevalence of mild cognitive impairment. Sleep Med 2020; 75: 522‒30.
5. Daulatzai MA. Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. J Neurosci Res 2015; 93(12): 1778‒94.
6. Li L, Yu Q, Zhang JB, Chen M. Role of oxidative stress and sleep structure on cognitive dysfunction in patients with obstructive sleep apnea-hypopnea syndrome. J Southeast Univ (Med Sci Edit) 2014; 33(1): 71‒4.
7. Jansen EH, Beekhof PK, Viezeliene D, Muzakova V, Skalicky J. Long-term stability of oxidative stress biomarkers in human serum. Free Radical Res 2017; 51(11‒12): 970‒7.
8. de Raaff CAL, de Vries N, van Wagensveld BA. Obstructive sleep apnea and bariatric surgical guidelines: summary and update. Curr Opin Anaesthesiol 2018; 31(1): 104‒9.
9. Chung F, Liao P, Elsaid H, Islam S, Shapiro CM, Sun Y. Oxygen desaturation index from nocturnal oximetry: a sensitive and specific tool to detect sleep-disordered breathing in surgical patients. Anesth Analg. 2012;114:993–1000.
10. Zhang H, Yang F, Guo Y, Wang L, Fang F, Wu H, et al. The contribution of chronic intermittent hypoxia to OSAHS: From the perspective of serum extracellular microvesicle proteins. Metabolism 2018; 85: 97‒108.
11. Li Y, Wu J, Guo J, Yu L, Wang J, Li X, et al. The efficacy of different treatment approaches for pediatric OSAHS patients with mandibular retrognathia: a study protocol for a multicenter randomized controlled trial. Trials 2020; 21(1): 97‒108.
12. Kostopoulos K, Alhanatis E, Pampoukas K, Georgiopoulos G, Zourla A, Panoutsopoulos A, et al. CPAP therapy induces favorable short-term changes in epicardial fat thickness and vascular and metabolic markers in apparently healthy subjects with obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 2016; 20(2): 483‒93.
13. Kitamura T, Miyazaki S, Sulaiman HB, Akaike R, Ito Y, Suzuki H. Insomnia and obstructive sleep apnea as potential triggers of dementia: is personalized prediction and prevention of the pathological cascade applicable? EPMA J 2020; 11(3): 355–65.
14. Kerner NA, Roose SP. Obstructive Sleep Apnea is Linked to Depression and Cognitive Impairment: Evidence and Potential Mechanisms. Am J Geriatr Psychiatry 2016; 24(6): 496‒508.
15. Wu SQ, Liao QC, Xu XX, Sun L, Wang J, Chen R. Effect of CPAP therapy on C-reactive protein and cognitive impairment in patients with obstructive sleep apnea hypopnea syndrome. Sleep Breath 2016; 20(4): 1185‒92.
16. Wang J, Chen R, Peng WD, Zhang YL, Shen JC, Li J, et al. Association between obesity and cognition impairment in patients with moderate-to-severe obstructive sleep apnea-hypopnea syndrome. Zhonghua Yi Xue Za Zhi 2013; 93(48): 3817‒21. (Chinese)
17. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004; 291(16): 2013‒6.
18. Lu D, Li N, Yao X, Zhou L. Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome. Bosn J Basic Med Sci 2017; 17(1): 47‒53.
19. Jiang Q, Li TP, Pang B, Wang X, Wang YF. Severe obstructive sleep apnea-hypopnea syndrome with latent renal dysfunction: analysis of 238 cases. Nan Fang Yi Ke Da Xue Xue Bao 2016; 36(3): 339‒44. (Chinese)
20. Siqueira GSA, Hagemann PMS, Coelho DS, Santos FHD, Bertolucci PHF. Can MoCA and MMSE be interchangeable cognitive screening tools? A systematic review. Gerontologist 2019; 59(6): e743‒63.
21. Zhou L, Chen P, Peng Y, Ouyang R. Role of oxidative stress in the neurocognitive dysfunction of obstructive sleep apnea syndrome. Oxid Med Cell Longev 2016; 2016: 9626831.